Target Name: H4C4
NCBI ID: G8360
Review Report on H4C4 Target / Biomarker Content of Review Report on H4C4 Target / Biomarker
H4C4
Other Name(s): H4FB | histone cluster 1 H4 family member d | Histone H4 | dJ221C16.9 | H4 clustered histone 4 | H4C14 | translation initiation factor IF-2-like | H4/b | H4 histone family, member B | H4C8 | H4_HUMAN | H4C12 | histone cluster 1, H4d | H4C11 | H4C9 | H4C5 | H4C6 | H4C16 | H4C15 | H4C3 | H4C1 | DJ221C16.9 | H4C13 | HIST1H4D | H4C2 | histone 1, H4d | H4-16

H4C4: A Protein of Potential as A Drug Target and Biomarker

H4C4, also known as H4FB, is a protein that is expressed in various tissues throughout the body. It is a member of the H4 family of proteins, which are known for their role in cell signaling and inflammation. One of the unique features of H4C4 is its ability to interact with the protein FZDH1, which is a key regulator of the H4 family of proteins.

The H4C4 protein is involved in a variety of physiological processes in the body, including cell signaling, inflammation, and stress response. It has been shown to play a role in the regulation of cell proliferation, differentiation, and survival. H4C4 has also been shown to be involved in the regulation of inflammation and immune response, as well as in the regulation of cellular processes that are important for the development and maintenance of tissues.

One of the reasons for the interest in H4C4 is its potential as a drug target. The H4C4 protein has been shown to be involved in a variety of cellular processes that are important for the development and maintenance of tissues, and it is thought to be a promising target for the development of new therapies.

One of the ways in which H4C4 may be used as a drug target is by targeting the regulation of its expression and function. This can be done through the use of small molecules, such as drugs that can modulate the activity of the H4C4 protein. These small molecules can interact with the protein in a variety of ways, including modulating its stability, its localization in the cell, or its interactions with other proteins.

Another way in which H4C4 may be used as a drug target is by targeting its role in the regulation of cellular processes that are important for the development and maintenance of tissues. For example, H4C4 has been shown to play a role in the regulation of cell proliferation, differentiation, and survival, and drugs that can modulate these processes may be useful as targets for the development of new therapies.

In addition to its potential as a drug target, H4C4 is also of interest as a biomarker. The H4C4 protein is expressed in a variety of tissues throughout the body, including the brain, pancreas, and skin. This makes it a potential target for the development of diagnostic tests that can detect the expression of H4C4 in these tissues.

Overall, H4C4 is a protein that is of interest as a potential drug target and as a biomarker. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic agent.

Protein Name: H4 Clustered Histone 4

Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling

The "H4C4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H4C4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3 | HAUS4 | HAUS5 | HAUS6 | HAUS7 | HAUS8 | HAVCR1 | HAVCR1P1 | HAVCR2 | HAX1 | HAX1P1 | HBA1 | HBA2 | HBAP1 | HBB | HBBP1 | HBD | HBE1 | HBEGF | HBG1 | HBG2 | HBM | HBO1 complex | HBP1 | HBQ1 | HBS1L | HBZ | HBZP1 | HCAR1 | HCAR2 | HCAR3 | HCCAT5 | HCCS | HCFC1 | HCFC1R1 | HCFC2 | HCG11 | HCG14 | HCG15 | HCG17 | HCG18 | HCG20 | HCG21 | HCG22 | HCG23 | HCG25 | HCG26 | HCG27